Pathophysiological associations of transcallosal dysfunction in ALS

Area of Science:

• Neuroscience
• Neurology
• Motor Neuron Diseases

Background:

• The corpus callosum's involvement in amyotrophic lateral sclerosis (ALS) is known from neuropathological studies.
• Understanding transcallosal function alterations is crucial for ALS pathogenesis.

Purpose of the Study:

• To investigate if altered transcallosal function contributes to ALS development and progression.
• To correlate transcallosal function changes with functional disability in ALS patients.

Main Methods:

• Assessed transcallosal function and motor cortex excitability in 17 ALS patients and healthy controls.
• Measured transcallosal inhibition, short interval intracortical facilitation (SICF), and short interval intracortical inhibition (SICI).
• Utilized clinical and neurophysiological assessments for patient staging.

Main Results:

• ALS patients showed significantly reduced transcallosal inhibition compared to controls.
• Cortical hyperexcitability, indicated by reduced SICI and increased SICF, was observed in ALS.
• Reduced transcallosal inhibition correlated significantly with faster disease progression and muscle strength decline.

Conclusions:

• Transcallosal circuit dysfunction is a key pathophysiological mechanism in ALS.
• This dysfunction is linked to increased patient disability and accelerated disease progression.
• Therapies targeting transcallosal circuit restoration may benefit ALS treatment.